Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FQV7F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,143
Award facts
- Contract value 100% obligated
- $48,142.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 30, 2026, the Defense Logistics Agency awarded a delivery order valued at $48,142.87 to Amerisourcebergen Drug Corp for TALTZ 80 MG/ML Autoinjector. The contract is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 2, 2026. This delivery order falls under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a critical role in supplying medications and medical commodities to federal agencies, particularly the Department of Defense and Department of Veterans Affairs through various contract vehicles. The TALTZ autoinjector delivery represents one of numerous task orders executed under the larger DLA Medical Supply Chain framework, demonstrating the company's capability to efficiently fulfill government requirements for specialty medications across multiple therapeutic domains. As a single-award indefinite delivery contract holder, Cencora, Inc. and its subsidiary provide essential pharmaceutical support including specialty medications, brand-name and generic drugs, vaccines, and medical devices to military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FQV7F?
SPE2DR26FQV7F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FQV7F worth?
The government has obligated $48,143 on SPE2DR26FQV7F.
Is contract SPE2DR26FQV7F an order under another contract?
Yes. SPE2DR26FQV7F is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV7F competed?
The extent of competition for SPE2DR26FQV7F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award